The Efficacy of Dexamethasone Versus N-Acetylcysteine in Prevention of Post-Embolization Syndrome in Hepatocellular Carcinoma Patients: A Multicenter Randomized, Double-Blind, Double-Dummy, Non-Inferiority Trial.

Karasin P, Tantitanawat K, Charonpongsuntorn C, Suksamai A, Chirapongsathorn S

Open source

DOI
10.1111/ajco.70127
Published
2026 Jun 8
Container
Asia-Pacific journal of clinical oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/ajco.70127,
  title = {The Efficacy of Dexamethasone Versus N-Acetylcysteine in Prevention of Post-Embolization Syndrome in Hepatocellular Carcinoma Patients: A Multicenter Randomized, Double-Blind, Double-Dummy, Non-Inferiority Trial.},
  author = {Karasin P and Tantitanawat K and Charonpongsuntorn C and Suksamai A and Chirapongsathorn S},
  year = {2026},
  journal = {Asia-Pacific journal of clinical oncology},
  doi = {10.1111/ajco.70127},
  url = {https://doi.org/10.1111/ajco.70127}
}

RIS

TY  - JOUR
TI  - The Efficacy of Dexamethasone Versus N-Acetylcysteine in Prevention of Post-Embolization Syndrome in Hepatocellular Carcinoma Patients: A Multicenter Randomized, Double-Blind, Double-Dummy, Non-Inferiority Trial.
AU  - Karasin P
AU  - Tantitanawat K
AU  - Charonpongsuntorn C
AU  - Suksamai A
AU  - Chirapongsathorn S
PY  - 2026
JO  - Asia-Pacific journal of clinical oncology
DO  - 10.1111/ajco.70127
UR  - https://doi.org/10.1111/ajco.70127
ER  - 

APA

P, K., K, T., C, C., A, S., & S, C. (2026). The Efficacy of Dexamethasone Versus N-Acetylcysteine in Prevention of Post-Embolization Syndrome in Hepatocellular Carcinoma Patients: A Multicenter Randomized, Double-Blind, Double-Dummy, Non-Inferiority Trial.. Asia-Pacific journal of clinical oncology. https://doi.org/10.1111/ajco.70127

Source records